These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1125 related items for PubMed ID: 25854264
21. Maternal serum biomarkers of placental insufficiency at 24-28 weeks of pregnancy in relation to the risk of delivering small-for-gestational-age infant in Sylhet, Bangladesh: a prospective cohort study. Rahman S, Islam MS, Roy AK, Hasan T, Chowdhury NH, Ahmed S, Raqib R, Baqui AH, Khanam R. BMC Pregnancy Childbirth; 2024 Jun 10; 24(1):418. PubMed ID: 38858611 [Abstract] [Full Text] [Related]
22. Role of sFlt-1/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia. Graupner O, Karge A, Flechsenhar S, Seiler A, Haller B, Ortiz JU, Lobmaier SM, Axt-Fliedner R, Enzensberger C, Abel K, Kuschel B. Arch Gynecol Obstet; 2020 Feb 10; 301(2):375-385. PubMed ID: 31734756 [Abstract] [Full Text] [Related]
27. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia. Molvarec A, Szarka A, Walentin S, Szucs E, Nagy B, Rigó J. Hypertens Res; 2010 Sep 10; 33(9):892-8. PubMed ID: 20535121 [Abstract] [Full Text] [Related]
28. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population. Kienast C, Moya W, Rodriguez O, Jijón A, Geipel A. J Matern Fetal Neonatal Med; 2016 Sep 10; 29(4):537-43. PubMed ID: 25708492 [Abstract] [Full Text] [Related]
29. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. Erez O, Romero R, Espinoza J, Fu W, Todem D, Kusanovic JP, Gotsch F, Edwin S, Nien JK, Chaiworapongsa T, Mittal P, Mazaki-Tovi S, Than NG, Gomez R, Hassan SS. J Matern Fetal Neonatal Med; 2008 May 10; 21(5):279-87. PubMed ID: 18446652 [Abstract] [Full Text] [Related]
30. Levels of maternal serum angiogenic factors in third-trimester normal pregnancies: reference ranges, influence of maternal and pregnancy factors and fetoplacental Doppler indices. Lobmaier SM, Figueras F, Mercade I, Crovetto F, Peguero A, Parra-Saavedra M, Ortiz JU, Crispi F, Gratacós E. Fetal Diagn Ther; 2014 May 10; 36(1):38-43. PubMed ID: 24903330 [Abstract] [Full Text] [Related]
31. Biomarkers of impaired placentation at 35-37 weeks' gestation in the prediction of adverse perinatal outcome. Ciobanou A, Jabak S, De Castro H, Frei L, Akolekar R, Nicolaides KH. Ultrasound Obstet Gynecol; 2019 Jul 10; 54(1):79-86. PubMed ID: 31100188 [Abstract] [Full Text] [Related]
34. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ. Circulation; 2010 Aug 03; 122(5):478-87. PubMed ID: 20644016 [Abstract] [Full Text] [Related]
36. Maternal fish consumption, fatty acid levels and angiogenic factors: The Generation R Study. Bautista Niño PK, Tielemans MJ, Schalekamp-Timmermans S, Steenweg-de Graaff J, Hofman A, Tiemeier H, Jaddoe VW, Steegers EA, Felix JF, Franco OH. Placenta; 2015 Oct 03; 36(10):1178-84. PubMed ID: 26278058 [Abstract] [Full Text] [Related]
37. Contrasting effects of chronic hypoxia and nitric oxide synthase inhibition on circulating angiogenic factors in a rat model of growth restriction. Bahtiyar MO, Buhimschi C, Ravishankar V, Copel J, Norwitz E, Julien S, Guller S, Buhimschi IA. Am J Obstet Gynecol; 2007 Jan 03; 196(1):72.e1-6. PubMed ID: 17240241 [Abstract] [Full Text] [Related]